Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
67.60
+1.20 (1.81%)
At close: Sep 3, 2026

Navana Pharmaceuticals Cash Flow Statement

Millions BDT. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
606.13487.81404.63356.94274202.29
Depreciation & Amortization
288.52320.65214.96210.41165.8487.27
Other Amortization
0.330.220.22-0.220.11
Loss (Gain) From Sale of Assets
7.657.65-1.18--0.470
Loss (Gain) From Sale of Investments
-14.810.46-123.1446.8-82.9-
Other Operating Activities
168.7175.8341.5134.99147.0875.47
Change in Accounts Receivable
-209.13-175.36-218.89-253.42-84.93-74.38
Change in Inventory
386.788.47-620.6-344.07-200.76-95.7
Change in Accounts Payable
681.76417.03332.93152.2279.448.78
Change in Other Net Operating Assets
459.42482.28376.88-110.13-98.16-82.11
Operating Cash Flow
2,3751,815707.3193.74199.36121.75
Operating Cash Flow Growth
45.33%156.61%265.07%-2.82%63.74%-39.58%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-481.66-370.89-1,332-1,598-1,359-520.75
Sale of Property, Plant & Equipment
--1.48---
Investment in Securities
-52.99-10.4613.48-2.33-171.4853.65
Other Investing Activities
0.120.321.142.793.26-1.17
Investing Cash Flow
-534.53-381.03-1,316-1,598-1,527-468.28

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
--942.141,3841,551360.66
Long-Term Debt Issued
--121.97-17.7493.09
Total Debt Issued
-22.77-1,0641,3841,569453.75
Short-Term Debt Repaid
--724.88----
Long-Term Debt Repaid
--51.82-16.26-66.46-45.83-72.02
Lease Payments
-39.17-43.55-16.26-5.66-36.17-28.49
Total Debt Repaid
-1,079-776.7-16.26-66.46-45.83-72.02
Net Debt Issued (Repaid)
-1,102-776.71,0481,3181,523381.73
Issuance of Common Stock
---750--
Common Dividends Paid
-51.35-41.56-136.88-113.15--
Other Financing Activities
-657.18-698.96-475.12-175.98-154.73-64.15
Financing Cash Flow
-1,810-1,517435.841,7781,368317.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
-1.22---0.05-
Miscellaneous Cash Flow Adjustments
0--0.05-0-
Net Cash Flow
29.47-83.24-173.16374.540.65-28.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
1,8941,444-625.1-1,404-1,160-399
Free Cash Flow Growth
258.43%-----
Free Cash Flow Margin
17.92%16.33%-9.06%-24.61%-24.37%-11.06%
Free Cash Flow Per Share
17.5013.44-5.82-14.13-14.45-4.97
Levered Free Cash Flow
1,2851,039-1,180-2,393-1,836-461.76
Unlevered Free Cash Flow
1,6671,493-889.89-2,246-1,711-414.77
Free Cash Flow After Leases
1,8541,401-641.36-1,410-1,196-427.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
657.18698.96475.12157.9142.8364.15
Cash Income Tax Paid
-148.76131.47101110.2788.79
Change in Working Capital
1,319812.42-129.68-555.4-304.41-243.4